Trial ID or NCT#

NCT03547206

Status

recruiting iconRECRUITING

Purpose

This study is designed as a double-masked, randomized, placebo-controlled, clinical study to evaluate the efficacy and safety of subcutaneous (SC) administration of RPh201 in participants with previous NAION. All participants enrolled in Cohort A of the study will have a documented history of NAION for at least 12 months and at most, five years prior to enrollment. Participants enrolled in Cohort B of the study will have a documented history of NAION for at least 6 months and at most, three years prior to enrollment.

Official Title

A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION

Eligibility Criteria

Ages Eligible for Study: Older than 50 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Y. Joyce Liao, MD, PhD
Y. Joyce Liao, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology and of Neurology at the Stanford University Medical Center
Shannon Beres, MD
Neuro-ophthalmology specialist, General neurologist
Clinical Assistant Professor, Neurology & Neurological Sciences Clinical Assistant Professor, Ophthalmology
Heather E. Moss, MD, PhD
Heather E. Moss, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology and of Neurology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Mariana Nunez
(650) 497-7846